Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01718197 · ClinicalTrials.gov registry record
Severe Asthma Research Program (SARP)- San Francisco Clinical Site
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 151
- Enrollment target
NCT01718197 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 151 participants.
The verdict
NCT01718197 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 151 participants
- Enrollment target
Study Summary
The mission of SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2012-11 |
| Est. Completion | 2021-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01718197
The ClinicalTrials.gov registry entry for NCT01718197 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01718197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01718197 about?
NCT01718197 is a clinical study titled "Severe Asthma Research Program (SARP)- San Francisco Clinical Site". The mission of SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
What is the current status of trial NCT01718197?
This trial is currently completed. The enrollment target is 151 participants. The study started on 2012-11. Estimated completion is 2021-03-01.
Who is sponsoring clinical trial NCT01718197?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.